Drug Approval | August 22, 2023
Jiangsu Hengrui Pharmaceuticals gets NMPA approval of oteseconazole Ccapsules
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Need to harmonize traditional and modern medicine to combat alarming health problems
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Subscribe To Our Newsletter & Stay Updated
